For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Tricida, Inc.

USPTO Granted Patents = 11

CIPO Patents = 1

EPO Patents = 5

Trademarks = 3

Forward Citations = 92

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Gerrit Klaerner (11 out of 50 patents)

Eric F Connor (10 out of 45 patents)

Randi K Gbur (10 out of 13 patents)

4. Matthew J Kade (10 out of 13 patents)

5. Paul H Kierstead (10 out of 13 patents)

6. Jerry M Buysse (10 out of 28 patents)

7. Kalpesh N Biyani (10 out of 24 patents)

8. Son H Nguyen (10 out of 18 patents)

9. Scott M Tabakman (10 out of 29 patents)

10. Michael James Cope (9 out of 26 patents)

11. Jun Shao (1 out of 13 patents)

12. Dawn Parsell Otto (1 out of 2 patents)

11 patents: Sort by Forward Citations

1. 11406661 - HCl-binding compositions for and methods of treating acid-base disorders (2022-08-09),

2. 11311571 - Proton-binding polymers for oral administration (2022-04-26),

3. 11266684 - Compositions for and method of treating acid-base disorders (2022-03-08),

4. 11197887 - Proton-binding polymers for oral administration (2021-12-14),

5. 10934380 - Crosslinked poly(allylamine) polymer pharmaceutical compositions (2021-03-02),

6. 10391118 - Proton-binding polymers for oral administration (2019-08-27),

7. 10369169 - Proton-binding polymers for oral administration (2019-08-06),

8. 10363268 - Proton-binding polymers for oral administration (2019-07-30),

9. 9993500 - Proton-binding polymers for oral administration (2018-06-12),

10. 9925214 - Proton-binding polymers for oral administration (2018-03-27),

11. 9205107 - Proton-binding polymers for oral administration (2015-12-08),

Tricida, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on developing innovative therapies for patients with chronic kidney disease. The company specializes in the research and development of novel treatments aimed at addressing unmet medical needs in this domain. Tricida's primary technology platform is centered around its proprietary drug candidates, which are designed to improve patient outcomes and enhance quality of life for those affected by kidney-related conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#98 in South San Francisco, CA

#6,532 in California

#27,490 in US

#51,714 in the World

South San Francisco, CA, United States of America

Tricida, Inc.

Forward Citations = 92

12 inventors:

Gerrit Klaerner (11 out of 50 patents)

Eric F Connor (10 out of 45 patents)

Randi K Gbur (10 out of 13 patents)

4. Matthew J Kade (10 out of 13 patents)

5. Paul H Kierstead (10 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…